抑制 PRMT9 可激发急性髓细胞白血病的免疫反应

IF 23.5 1区医学 Q1 ONCOLOGY

Nature cancer Pub Date : 2024-04-29 DOI:10.1038/s43018-024-00753-w

Antonella Santoro, Raffaella Di Micco

引用次数: 0

摘要

精氨酸甲基化对肿瘤的维持至关重要。在急性髓性白血病中，PRMT9 水平升高，抑制 PRMT9 可减少参与 DNA 损伤反应和 RNA 翻译的蛋白质的精氨酸甲基化，从而根除白血病。这激活了 cGAS-STING 通路，从而引发针对白血病的免疫反应。以DNA损伤反应机制为表观遗传学靶标可能会增强抗肿瘤免疫力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

PRMT9 inhibition sparks immune responses in AML

查看原文本刊更多论文

PRMT9 inhibition sparks immune responses in AML

Arginine methylation is crucial for tumor maintenance. PRMT9 levels are elevated in acute myeloid leukemia, and its inhibition eradicates leukemia by diminishing arginine methylation of proteins involved in DNA damage response and RNA translation. This activates the cGAS–STING pathway, which triggers immune responses directed against leukemia. Epigenetic targeting of DNA-damage-response mechanisms may bolster anti-tumor immunity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature cancer Medicine-Oncology

CiteScore

31.10

自引率

1.80%

发文量

129

期刊介绍： Cancer is a devastating disease responsible for millions of deaths worldwide. However, many of these deaths could be prevented with improved prevention and treatment strategies. To achieve this, it is crucial to focus on accurate diagnosis, effective treatment methods, and understanding the socioeconomic factors that influence cancer rates. Nature Cancer aims to serve as a unique platform for sharing the latest advancements in cancer research across various scientific fields, encompassing life sciences, physical sciences, applied sciences, and social sciences. The journal is particularly interested in fundamental research that enhances our understanding of tumor development and progression, as well as research that translates this knowledge into clinical applications through innovative diagnostic and therapeutic approaches. Additionally, Nature Cancer welcomes clinical studies that inform cancer diagnosis, treatment, and prevention, along with contributions exploring the societal impact of cancer on a global scale. In addition to publishing original research, Nature Cancer will feature Comments, Reviews, News & Views, Features, and Correspondence that hold significant value for the diverse field of cancer research.